Analyst Ratings (USA)
The U.S. analyst outlook remains cautiously positive, with positive recommendations accounting for most of today’s coverage and upgrades continuing to outnumber downgrades. However, price-target reductions exceeded increases, indicating that analysts are becoming more disciplined about valuations and near-term earnings expectations. Technology, healthcare and biotechnology continue to attract the strongest interest, while energy, financial and consumer stocks show a more mixed outlook. Overall, sentiment remains constructive, but analysts are increasingly favouring companies with clear earnings momentum, strong balance sheets and reliable growth prospects.
Wall Street analysts released 199 rating and price-target actions covering 160 U.S.-listed companies on September 22, 2026. The daily activity included 11 upgrades, 5 downgrades, 32 target increases, 38 target reductions, 34 new coverage initiations, 12 newly stated price targets and 67 reiterated ratings.
Complete U.S. Analyst Ratings
| Company Name | Stock Symbol | Analyst | Action | Rating | New Target Price | Old Target Price |
|---|---|---|---|---|---|---|
| Abivax | ABVX | Barclays | Maintains | Overweight | $148.00 | |
| Abivax | ABVX | Truist Financial | Target Down | Buy | $151.00 | $155.00 |
| Abivax | ABVX | Wedbush | Target Down | Neutral | $118.00 | $140.00 |
| Adaptive Biotechnologies | ADPT | BTIG Research | Target Up | Buy | $34.00 | $25.00 |
| Adaptive Biotechnologies | ADPT | National Bank Financial | Target Set | $34.00 | ||
| Advanced Energy Industries | AEIS | Cantor Fitzgerald | Maintains | Overweight | ||
| Alaska Air Group | ALK | UBS Group | Maintains | Buy | $54.00 | $52.00 |
| Alcoa | AA | Freedom Broker | Target Up | Buy | $76.00 | $64.00 |
| Alkermes | ALKS | Robert W. Baird | Target Up | Outperform | $61.00 | $58.00 |
| Alkermes | ALKS | Royal Bank Of Canada | Maintains | Outperform | $56.00 | |
| Allegion | ALLE | Evercore | Maintains | Outperform | $180.00 | |
| Amphenol | APH | BNP Paribas Exane | Target Up | Outperform | $110.00 | $107.50 |
| Amrize | AMRZ | UBS Group | Target Down | Neutral | $42.00 | $57.00 |
| AnaptysBio | ANAB | Cantor Fitzgerald | Maintains | Overweight | ||
| AnaptysBio | ANAB | HC Wainwright | Maintains | Buy | $95.00 | |
| Anixa Biosciences | ANIX | HC Wainwright | Target Down | Buy | $6.00 | $7.00 |
| Antero Midstream | AM | Capital One Financial | Upgrades | Overweight | $25.00 | |
| ArriVent BioPharma | AVBP | Cantor Fitzgerald | Maintains | Overweight | ||
| Atlanticus | ATLC | BTIG Research | Maintains | Buy | $179.00 | |
| AvePoint | AVPT | Cantor Fitzgerald | Maintains | Overweight | ||
| BankUnited | BKU | Citigroup | Maintains | Sell | ||
| Bicara Therapeutics | BCAX | HSBC | Downgrades | Equal Weight | ||
| Bilibili | BILI | BNP Paribas Exane | Initiates | Outperform | $23.00 | |
| BitMine Immersion Technologies | BMNR | B. Riley Financial | Target Up | Buy | $34.00 | $30.00 |
| Brinker International | EAT | Northcoast Research | Upgrades | Buy | $275.00 | |
| Butterfly Network | BFLY | Needham & Company LLC | Initiates | Buy | $10.00 | |
| Cal-Maine Foods | CALM | Stephens | Target Set | Equal Weight | $80.00 | $90.00 |
| Camtek | CAMT | Cantor Fitzgerald | Maintains | Neutral | $175.00 | |
| Capri | CPRI | Jefferies Financial Group | Maintains | Hold | ||
| Carnival | CCL | Deutsche Bank Aktiengesellschaft | Target Set | $32.00 | ||
| Carnival | CCL | TD Cowen | Target Down | Buy | $32.00 | $34.00 |
| Celldex Therapeutics | CLDX | Cantor Fitzgerald | Target Up | Overweight | $72.00 | $61.00 |
| Celldex Therapeutics | CLDX | HC Wainwright | Target Up | Buy | $64.00 | $42.00 |
| Celldex Therapeutics | CLDX | Stifel Nicolaus | Target Set | $68.00 | ||
| ChargePoint | CHPT | UBS Group | Maintains | Neutral | $9.00 | $8.00 |
| Chord Energy | CHRD | UBS Group | Target Down | Buy | $184.00 | $189.00 |
| Cintas | CTAS | Citigroup | Maintains | Sell | $180.00 | $175.00 |
| Cisco Systems | CSCO | Piper Sandler | Target Down | Neutral | $125.00 | $132.00 |
| Coinbase Global | COIN | William Blair | Maintains | Outperform | ||
| Columbia Banking System | COLB | Citigroup | Target Down | Neutral | $31.00 | $32.00 |
| Connect Biopharma | CNTB | Oppenheimer | Target Down | Outperform | $5.00 | |
| Constellation Brands | STZ | Barclays | Target Down | Equal Weight | $122.00 | $132.00 |
| Constellation Brands | STZ | Citigroup | Target Down | Buy | $165.00 | $185.00 |
| Costco Wholesale | COST | Evercore | Maintains | Outperform | ||
| Crane NXT | CXT | Jefferies Financial Group | Initiates | Buy | $60.00 | |
| CRH | CRH | UBS Group | Target Down | Buy | $135.00 | $147.00 |
| CVRx | CVRX | Canaccord Genuity Group | Target Set | $5.00 | ||
| CVS Health | CVS | UBS Group | Maintains | Buy | ||
| D.R. Horton | DHI | BTIG Research | Maintains | Buy | $174.00 | |
| D.R. Horton | DHI | Keefe, Bruyette & Woods | Target Down | Market Perform | $160.00 | $167.00 |
| Darling Ingredients | DAR | UBS Group | Target Up | Buy | $88.00 | $78.00 |
| Deep Fission | FISN | Roth Capital | Initiates | Buy | $18.00 | |
| Driven Brands | DRVN | Barclays | Initiates | Equal Weight | $14.00 | |
| East West Bancorp | EWBC | Citigroup | Target Down | Buy | $152.00 | $156.00 |
| Eldorado Gold | EGO | Bank of America | Upgrades | Buy | $54.00 | $32.00 |
| Elemental Royalty | ELE | HC Wainwright | Target Down | Buy | $31.00 | $33.00 |
| Eli Lilly and Company | LLY | TD Cowen | Maintains | Buy | $1,250.00 | |
| Endava | DAVA | Deutsche Bank Aktiengesellschaft | Target Down | Hold | $2.00 | $3.00 |
| Endava | DAVA | TD Cowen | Maintains | Hold | $3.50 | |
| Endava | DAVA | William Blair | Downgrades | Underperform | ||
| Energy Transfer | ET | Capital One Financial | Initiates | Overweight | $26.00 | |
| Energy Transfer | ET | Melius Research | Initiates | Hold | $25.00 | |
| Entera Bio | ENTX | Cantor Fitzgerald | Initiates | Overweight | ||
| Enterprise Products Partners | EPD | Capital One Financial | Initiates | Equal Weight | $42.00 | |
| Enterprise Products Partners | EPD | Melius Research | Initiates | Hold | $42.00 | |
| Enterprise Products Partners | EPD | Royal Bank Of Canada | Maintains | Outperform | $42.00 | |
| Equifax | EFX | Wells Fargo & Company | Target Down | Overweight | $200.00 | $212.00 |
| Ericsson | ERIC | Morgan Stanley | Downgrades | Underweight | $9.00 | $11.00 |
| Essent Group | ESNT | BTIG Research | Initiates | Neutral | ||
| Everest Group | EG | Rosenblatt Securities | Target Set | $455.00 | ||
| Everest Group | EG | Royal Bank Of Canada | Initiates | Outperform | $455.00 | |
| Exelon | EXC | Argus | Target Down | Buy | $49.00 | $52.00 |
| Fair Isaac | FICO | Wells Fargo & Company | Target Down | Overweight | $1,350.00 | $1,450.00 |
| Ferrovial | FER | Morgan Stanley | Maintains | Overweight | ||
| Fifth Third Bancorp | FITB | Citigroup | Upgrades | Buy | $62.00 | $59.00 |
| First Horizon | FHN | Citigroup | Target Down | Buy | $28.00 | $28.50 |
| First Solar | FSLR | Glj Research | Target Set | $250.00 | ||
| FormFactor | FORM | Cantor Fitzgerald | Maintains | Overweight | ||
| Forward Industries | FWDI | B. Riley Financial | Target Up | Buy | $11.00 | $9.00 |
| GE HealthCare Technologies | GEHC | Needham & Company LLC | Initiates | Buy | $93.00 | |
| Glaukos | GKOS | Jefferies Financial Group | Target Up | Buy | $210.00 | $190.00 |
| GRAIL | GRAL | Robert W. Baird | Target Up | Outperform | $118.00 | $96.00 |
| Gulfport Energy | GPOR | Pickering Energy Partners | Initiates | Outperform | ||
| Hancock Whitney | HWC | Citigroup | Target Down | Buy | $86.00 | $87.00 |
| HeartBeam | BEAT | HC Wainwright | Downgrades | Neutral | ||
| Heartflow | HTFL | Canaccord Genuity Group | Target Up | Buy | $56.00 | $45.00 |
| Heritage Financial | HFWA | Brean Capital | Upgrades | Buy | $33.00 | |
| Heritage Financial | HFWA | Capital One Financial | Target Set | $33.00 | ||
| Hinge Health | HNGE | Robert W. Baird | Target Up | Neutral | $90.00 | $85.00 |
| Hyperfine | HYPR | BTIG Research | Maintains | Buy | $2.00 | |
| IDEAYA Biosciences | IDYA | Cantor Fitzgerald | Maintains | Overweight | ||
| Incyte | INCY | Royal Bank Of Canada | Maintains | Sector Perform | $109.00 | |
| Ionis Pharmaceuticals | IONS | JPMorgan Chase & Co. | Target Down | Overweight | $70.00 | $76.00 |
| IonQ | IONQ | Wedbush | Maintains | Outperform | $75.00 | |
| iRadimed | IRMD | Needham & Company LLC | Initiates | Hold | ||
| Johnson & Johnson | JNJ | UBS Group | Maintains | Buy | ||
| KBR | KBR | Oppenheimer | Target Down | Outperform | $50.00 | $60.00 |
| KeyCorp | KEY | Citigroup | Maintains | Neutral | ||
| Kinder Morgan | KMI | Capital One Financial | Initiates | Equal Weight | $36.00 | |
| Kinder Morgan | KMI | Melius Research | Initiates | Buy | $38.00 | |
| Kinder Morgan | KMI | Royal Bank Of Canada | Target Up | Sector Perform | $36.00 | $35.00 |
| KindlyMD | NAKA | B. Riley Financial | Target Up | Buy | $13.00 | $11.00 |
| Kraft Heinz | KHC | TD Cowen | Maintains | Hold | $22.00 | |
| Kymera Therapeutics | KYMR | Stifel Nicolaus | Target Up | Buy | $152.00 | $132.00 |
| Lennar | LEN | Keefe, Bruyette & Woods | Target Down | Underperform | $75.00 | $85.00 |
| Lexeo Therapeutics | LXEO | Raymond James Financial | Maintains | Strong Buy | ||
| Liftoff Mobile | LFTO | Piper Sandler | Initiates | Neutral | $19.00 | |
| Lipocine | LPCN | Cantor Fitzgerald | Maintains | Overweight | ||
| Lithia Motors | LAD | Citigroup | Target Down | Buy | $409.00 | $455.00 |
| Maze Therapeutics | MAZE | BTIG Research | Maintains | Buy | $46.00 | |
| McGraw Hill | MH | BTIG Research | Maintains | Buy | $17.00 | |
| Meta Platforms | META | Bank of America | Maintains | Buy | $810.00 | |
| Meta Platforms | META | Jefferies Financial Group | Target Up | Buy | $875.00 | $710.00 |
| MetLife | MET | Piper Sandler | Upgrades | Overweight | $110.00 | $99.00 |
| MGIC Investment | MTG | BTIG Research | Initiates | Neutral | ||
| Microsoft | MSFT | Oppenheimer | Target Up | Outperform | $570.00 | $515.00 |
| Moderna | MRNA | UBS Group | Maintains | Neutral | ||
| Motorola Solutions | MSI | Piper Sandler | Target Up | Overweight | $531.00 | $530.00 |
| NetEase | NTES | BNP Paribas Exane | Initiates | Outperform | $180.00 | |
| Netflix | NFLX | BMO Capital Markets | Maintains | Outperform | ||
| Netflix | NFLX | HSBC | Downgrades | Hold | $76.00 | $96.00 |
| Nextpower | NXT | Robert W. Baird | Target Down | Outperform | $116.00 | $156.00 |
| NMI | NMIH | BTIG Research | Initiates | Buy | $54.00 | |
| NVR | NVR | BTIG Research | Target Set | $7,125.00 | ||
| Obsidian Therapeutics | OBX | Leerink Partners | Initiates | Outperform | $32.00 | |
| Okta | OKTA | Robert W. Baird | Target Up | Outperform | $200.00 | $185.00 |
| Okta | OKTA | Scotiabank | Target Up | Sector Outperform | $190.00 | $165.00 |
| Old National Bancorp | ONB | Citigroup | Target Down | Buy | $30.00 | $31.00 |
| Omeros | OMER | Cantor Fitzgerald | Upgrades | Overweight | $22.00 | |
| ON | ONON | The Goldman Sachs Group | Maintains | Buy | ||
| ONEOK | OKE | Capital One Financial | Initiates | Overweight | $110.00 | |
| Option Care Health | OPCH | UBS Group | Maintains | Buy | ||
| Paramount Skydance | PSKY | Citizens Jmp | Maintains | Market Outperform | $14.00 | |
| Paramount Skydance | PSKY | Morgan Stanley | Target Up | Overweight | $11.50 | $10.00 |
| Pharming Group | PHAR | HC Wainwright | Maintains | Buy | $37.00 | |
| Pilgrim’s Pride | PPC | UBS Group | Maintains | Neutral | ||
| Popular | BPOP | Citigroup | Target Down | Buy | $192.00 | $200.00 |
| Priority Technology | PRTH | Keefe, Bruyette & Woods | Target Up | Market Perform | $8.00 | $6.50 |
| Prosperity Bancshares | PB | Citigroup | Target Down | Neutral | $77.00 | $79.00 |
| PTC Therapeutics | PTCT | Cantor Fitzgerald | Target Up | Overweight | $137.00 | $130.00 |
| Q2 | QTWO | Piper Sandler | Maintains | Overweight | $82.00 | |
| Quince Therapeutics | QNCX | Citigroup | Upgrades | Outperform | ||
| Quince Therapeutics | QNCX | Citizens Jmp | Upgrades | Outperform | $77.00 | |
| Radian Group | RDN | BTIG Research | Initiates | Buy | $48.00 | |
| RadNet | RDNT | Raymond James Financial | Maintains | Strong Buy | ||
| Ralliant | RAL | Evercore | Maintains | Outperform | ||
| Real Brokerage | REAX | JonesTrading | Maintains | Buy | $40.00 | |
| RenaissanceRe | RNR | Jefferies Financial Group | Upgrades | Market Outperform | ||
| RenaissanceRe | RNR | Royal Bank Of Canada | Initiates | Sector Perform | $365.00 | |
| Rush Street Interactive | RSI | Citigroup | Maintains | Market Outperform | ||
| Rush Street Interactive | RSI | Citizens Jmp | Maintains | Market Outperform | $34.00 | |
| RxSight | RXST | Bank of America | Target Down | Underperform | $5.50 | $6.50 |
| RxSight | RXST | Jefferies Financial Group | Target Down | Hold | $5.75 | $6.50 |
| Sandisk | SNDK | Rosenblatt Securities | Initiates | Buy | $2,400.00 | |
| SAP | SAP | Citigroup | Maintains | Buy | ||
| SAP | SAP | Jefferies Financial Group | Maintains | Buy | $260.00 | |
| Sharplink Gaming | SBET | B. Riley Financial | Maintains | Buy | $14.00 | $12.00 |
| Sherwin-Williams | SHW | Royal Bank Of Canada | Maintains | Outperform | $420.00 | |
| SiriusPoint | SPNT | Royal Bank Of Canada | Initiates | Outperform | $30.00 | |
| Solana | HSDT | B. Riley Financial | Target Up | Buy | $4.00 | $3.50 |
| SoundHound AI | SOUN | Piper Sandler | Target Down | Neutral | $6.00 | $7.00 |
| STAAR Surgical | STAA | Jefferies Financial Group | Target Down | Buy | $23.00 | $28.00 |
| Strategy | MSTR | B. Riley Financial | Target Up | Buy | $195.00 | $175.00 |
| Strive | ASST | B. Riley Financial | Target Up | Buy | $33.00 | $26.00 |
| Stryker | SYK | TD Cowen | Target Down | Hold | $298.00 | $355.00 |
| Summit Therapeutics | SMMT | Cantor Fitzgerald | Maintains | Overweight | ||
| Terrestrial Energy | IMSR | Roth Capital | Initiates | Buy | $15.00 | |
| Texas Capital Bancshares | TCBI | Citigroup | Target Down | Neutral | $104.00 | $107.00 |
| Tiziana Life Sciences | TLSA | BTIG Research | Maintains | Buy | ||
| Travere Therapeutics | TVTX | HC Wainwright | Maintains | Buy | $67.00 | |
| Travere Therapeutics | TVTX | Wedbush | Maintains | Outperform | $76.00 | |
| Turning Point Brands | TPB | Oppenheimer | Target Down | Outperform | $90.00 | $130.00 |
| Twilio | TWLO | Rosenblatt Securities | Target Up | Buy | $290.00 | $275.00 |
| Twilio | TWLO | TD Cowen | Target Up | Buy | $300.00 | $260.00 |
| Tyra Biosciences | TYRA | HC Wainwright | Target Down | Buy | $29.00 | $30.00 |
| Tyra Biosciences | TYRA | Oppenheimer | Maintains | Outperform | $40.00 | $50.00 |
| U.S. Bancorp | USB | Citigroup | Maintains | Buy | ||
| Upstart | UPST | BTIG Research | Maintains | Buy | $43.00 | |
| Valero Energy | VLO | Jefferies Financial Group | Maintains | Hold | $401.00 | |
| Vicor | VICR | Needham & Company LLC | Maintains | Buy | $320.00 | |
| Vicor | VICR | Roth Capital | Maintains | Buy | $375.00 | |
| Viking Therapeutics | VKTX | HC Wainwright | Maintains | Buy | ||
| Viking Therapeutics | VKTX | Morgan Stanley | Maintains | Overweight | ||
| Viking Therapeutics | VKTX | Oppenheimer | Target Set | $120.00 | ||
| Viridian Therapeutics | VRDN | Royal Bank Of Canada | Target Up | Outperform | $38.00 | $36.00 |
| W.P. Carey | WPC | Benchmark | Initiates | Buy | ||
| W.P. Carey | WPC | Jefferies Financial Group | Initiates | Buy | $73.00 | |
| Wabash National | WNC | DA Davidson | Maintains | Buy | $20.00 | |
| Warner Bros. Discovery | WBD | Morgan Stanley | Target Up | Equal Weight | $31.00 | $29.00 |
| Warner Bros. Discovery | WBD | Morgan Stanley | Maintains | Positive | $31.00 | |
| West Pharmaceutical Services | WST | Morgan Stanley | Upgrades | Overweight | $400.00 | $365.00 |
| Western Alliance Bancorporation | WAL | Citigroup | Target Down | Buy | $95.00 | $98.00 |
| Western Alliance Bancorporation | WAL | Raymond James Financial | Initiates | Outperform | $90.00 | |
| Williams Companies | WMB | Capital One Financial | Initiates | Overweight | $92.00 | |
| Williams Companies | WMB | Melius Research | Initiates | Buy | $84.00 | |
| Xometry | XMTR | Raymond James Financial | Target Set | $120.00 | ||
| Xometry | XMTR | Rosenblatt Securities | Target Up | Buy | $120.00 | $110.00 |
| Yesway | YSWY | William Blair | Initiates | Outperform | ||
| YETI | YETI | Canaccord Genuity Group | Target Set | $45.00 |
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.